ELIZABETH KUJALA: Open Payments
NPI 1215578414 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 74 payments from 33 companies in 2025. Trend: 2023 $152 · 2024 $546 · 2025 $1,712
Food & beverage: $1,593Education: $119
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $334 |
| Aveo Pharmaceuticals, Inc. | 2 | $119 |
| PFIZER INC. | 6 | $119 |
| Novocure Inc. | 1 | $112 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Eisai Inc. | 2 | $61 |
| ABBVIE INC. | 2 | $53 |
| Janssen Biotech, Inc. | 3 | $53 |
Products named: KISQALI, FOTIVDA, Optune Lua (NovoTTF-200T), KEYTRUDA, DATROWAY, Lenvima, OPDIVO, MONOFERRIC.
Industry payments across IN — which companies pay providers there.
